VERU INC. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
VERU INC. (VERU) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2026-08-10
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-09-30 was $8.63M, a 4334.22% increase year-over-year.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2025 was $10.78M, a 781.53% increase from fiscal 2024.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2024 was $1.22M, a 78.63% decline from fiscal 2023.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2023 was $5.72M.
- VERU INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2021 was $18.41M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month as first filed | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month as first filed | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $8.63M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | $8.63M derived: sum of 3 quarters · filed 2026-05-13 | $9.11M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | $8.63M derived: sum of 2 quarters · filed 2026-02-11 | $9.11M derived: sum of 3 quarters · filed 2026-08-10 | $10.09M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-09-30 | $8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $9.11M derived: sum of 2 quarters · filed 2026-08-10 | $10.09M derived: sum of 3 quarters · filed 2026-08-10 | $10.78M 10-K · filed 2025-12-17 | ||
| 2025-06-30 | $484.62K 10-Q · filed 2026-08-10 | $1.46M derived: sum of 2 quarters · filed 2026-08-10 | $2.15M 10-Q · filed 2026-08-10 | $2.35M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $974.30K 10-Q · filed 2026-05-13 | $1.67M 10-Q · filed 2026-05-13 | $1.86M derived: sum of 3 quarters · filed 2026-05-13 | $1.97M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $695.22K 10-Q · filed 2026-02-11 | $889.75K derived: sum of 2 quarters · filed 2026-02-11 | $999.75K derived: sum of 3 quarters · filed 2026-02-11 | $999.75K derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-09-30 | $194.54K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $304.54K derived: sum of 2 quarters · filed 2025-12-17 | $304.54K derived: sum of 3 quarters · filed 2025-12-17 | $1.22M 10-K · filed 2025-12-17 | ||
| 2024-06-30 | $110.00K 10-Q · filed 2025-08-12 | $110.00K derived: sum of 2 quarters · filed 2025-08-12 | $1.03M 10-Q · filed 2025-08-12 | $2.03M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $918.37K 10-Q · filed 2025-05-08 | $1.92M derived: sum of 3 quarters · filed 2025-05-08 | $6.64M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $918.37K 10-Q · filed 2025-02-13 | $1.92M derived: sum of 2 quarters · filed 2025-02-13 | $6.64M derived: sum of 3 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $5.72M derived: sum of 2 quarters · filed 2024-12-16 | $5.72M 10-K · filed 2024-12-16 | |||
| 2023-06-30 | $4.72M 10-Q · filed 2024-08-08 | $17.46M 10-Q · filed 2023-08-10 | $4.72M 10-Q · filed 2024-08-08 | $17.46M 10-Q · filed 2023-08-10 | ||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $0.00 derived: sum of 2 quarters · filed 2022-12-05 | $0.00 derived: sum of 3 quarters · filed 2022-12-05 | $18.41M 10-K · filed 2022-12-05 | ||
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $18.41M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $18.41M 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $18.41M 10-Q · filed 2022-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |